Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 17 de 17
Filter
1.
Cir Cir ; 88(3): 337-343, 2020.
Article in English | MEDLINE | ID: mdl-32539000

ABSTRACT

BACKGROUND: There is little information of intensive care unit (ICU) performance when it's relocated to a totally new and equipped area. OBJECTIVE: To analyze the clinical performance and use of resources of a new respiratory-ICU (nRICU) in a large third-level care hospital. METHOD: Cross-sectional, comparative study using prospective data of patients admitted from July 17, 2017 to July 17, 2018. The Rapoport adjusted method was used to obtain the standardized clinical performance index (SCPI) and the standardized resource use index (SRUI). RESULTS: Out of 354 patients, those who were readmissions or remained hospitalized and those whose treatment was withheld or withdrawn where excluded from the analysis. In 301 patients, the observed survival at hospital discharge was 63% while the expected survival was 67.7%. Values of SCPI and SRUI were -1.03 and 0.05 respectively, placing results in coordinates within two standard deviations when plotted in the Rapoport chart. There was a statistically significant difference in survival when comparing the study period with outcomes obtained in the RICU before its relocation (63% vs. 55%, p = 0.01). CONCLUSIONS: In its 1st year of operation, the nRICU had better clinical performance compared to the former RICU, with no change in the use of resources.


ANTECEDENTES: Existe poca información acerca del desempeño de una unidad de cuidados intensivos (UCI) cuando es reubicada en un área totalmente nueva y equipada. OBJETIVO: Analizar el rendimiento clínico y el uso de recursos de la nueva UCI respiratoria (UCIR) de un hospital grande de tercer nivel. MÉTODO: Estudio transversal, comparativo, con datos prospectivos de pacientes ingresados del 17 de julio de 2017 al 17 de julio de 2018. Se usa el método ajustado de Rapoport para obtener el índice de rendimiento clínico estandarizado (IRCE) y el índice de uso de recursos estandarizado (IRURE). RESULTADOS: De 354 pacientes fueron excluidos los reingresos, los pacientes aún hospitalizados y aquellos a quienes se limitó o retiró el tratamiento. En 301 pacientes la sobrevida hospitalaria fue del 63%, mientras que la sobrevida esperada fue del 67.7%. El IRCE fue −1.03 y el IRURE fue 0.05, situando el resultado en coordenadas dentro de dos desviaciones estándar en el gráfico de Rapoport. Hubo una diferencia estadísticamente significativa en la sobrevida comparando el periodo de estudio con resultados de la UCIR obtenidos antes de su reubicación (63 vs. 55%, p = 0.01). CONCLUSIONES: En su primer año de funcionamiento, la nueva UCIR tuvo mejor rendimiento clínico que la antigua, sin modificación en el uso de recursos.


Subject(s)
Hospital Design and Construction , Intensive Care Units/organization & administration , Adult , Aged , Critical Care/organization & administration , Cross-Sectional Studies , Diagnosis-Related Groups , Equipment and Supplies, Hospital/statistics & numerical data , Female , Health Resources/statistics & numerical data , Hospital Design and Construction/statistics & numerical data , Hospitals, General/organization & administration , Hospitals, General/statistics & numerical data , Humans , Intensive Care Units/statistics & numerical data , Male , Mexico , Middle Aged , Tertiary Care Centers/organization & administration , Tertiary Care Centers/statistics & numerical data , Treatment Outcome , Work Performance , Young Adult
2.
Rev. iberoam. micol ; 34(4): 233-236, oct.-dic. 2017. ilus
Article in Spanish | IBECS | ID: ibc-168719

ABSTRACT

Antecedentes. La mucormicosis pulmonar es una infección oportunista rara con alta mortalidad causada por hongos Mucorales. Los más frecuentes son Rhizopus, Mucor, Lichtheimia y Rhizomucor. Caso clínico. Se presenta el caso de una mujer de 56 años con diabetes mellitus tipo 2 y enfermedad renal crónica, receptora de un trasplante de riñón cadavérico dos años antes de su ingreso. Por este motivo recibió tratamiento inmunomodulador con timoglobulina, micofenolato de mofetilo, tacrolimus y prednisona. La paciente ingresó por un cuadro neumónico con tos, expectoración y disnea; una tomografía computarizada mostró una lesión cavitada en el lóbulo superior derecho. Con la sospecha de una aspergilosis pulmonar invasiva se comenzó un tratamiento antifúngico con voriconazol, sin mejoría. Se realizó una biopsia por aspiración con aguja fina, y en el cultivo de la misma creció Rhizomucor pusillus. La identificación se confirmó por PCR. A pesar del tratamiento con anfotericina B, la paciente presentó hemoptisis masiva incoercible, que provocó su fallecimiento. Conclusiones. La mucormicosis pulmonar es una infección rara que suele ser fatal en receptores de trasplante renal con terapia antirrechazo. Los mucorales producen fenómenos trombóticos, necrosis y destrucción tisular, que provocaron en nuestra paciente una hemoptisis incoercible. Es importante un diagnóstico preciso que permita instaurar un tratamiento quirúrgico adecuado y la administración de anfotericina B (AU)


Background. Pulmonary mucormycosis is a rare opportunistic infection with high mortality that is caused by species of Mucorales. The most common species involved are Rhizopus, Mucor, Lichtheimia, and Rhizomucor. Case report. A 56 year-old woman presented with a clinical history of diabetes mellitus type 2 and chronic renal disease. She underwent a cadaveric kidney transplantation two years before her admission, for which immunomodulating therapy with thymoglobulin, tacrolimus, mofetil-microphenolate and prednisone was established. The patient suffered a pneumonic process with cough, expectoration, and dyspnoea. The computed tomography scan showed a cavitation in the right upper lobe. With all these findings an invasive broncopulmonary aspergillosis was suspected and the patient began an antifungal treatment with voriconazole without improvement. Rhizomucor pusillus was isolated from a clinical specimen obtained by fine needle aspiration, and its identification was confirmed by PCR. After this finding amphotericin B was administered, but the patient had an uncontrolled haemoptysis and died. Conclusions. Pulmonary mucormycosis is a rare infection, usually fatal in kidney transplant recipients with anti-rejection therapy. Mucorales species usually produce thrombotic phenomena, associated with necrosis and parenchymal destruction that caused a fatal uncontrolled haemoptysis in our patient. Early diagnosis is important in order to perform any surgical treatment and to administer amphotericin B (AU)


Subject(s)
Humans , Male , Middle Aged , Hemoptysis/etiology , Kidney Transplantation , Mucormycosis/diagnosis , Lung Diseases, Fungal/diagnosis , Mucorales/isolation & purification , Diabetes Mellitus, Type 2/complications , Rhizomucor/pathogenicity , Antifungal Agents/therapeutic use
3.
Rev Iberoam Micol ; 34(4): 233-236, 2017.
Article in Spanish | MEDLINE | ID: mdl-28757006

ABSTRACT

BACKGROUND: Pulmonary mucormycosis is a rare opportunistic infection with high mortality that is caused by species of Mucorales. The most common species involved are Rhizopus, Mucor, Lichtheimia, and Rhizomucor. CASE REPORT: A 56 year-old woman presented with a clinical history of diabetes mellitus type 2 and chronic renal disease. She underwent a cadaveric kidney transplantation two years before her admission, for which immunomodulating therapy with thymoglobulin, tacrolimus, mofetil-microphenolate and prednisone was established. The patient suffered a pneumonic process with cough, expectoration, and dyspnoea. The computed tomography scan showed a cavitation in the right upper lobe. With all these findings an invasive broncopulmonary aspergillosis was suspected and the patient began an antifungal treatment with voriconazole without improvement. Rhizomucor pusillus was isolated from a clinical specimen obtained by fine needle aspiration, and its identification was confirmed by PCR. After this finding amphotericin B was administered, but the patient had an uncontrolled haemoptysis and died. CONCLUSIONS: Pulmonary mucormycosis is a rare infection, usually fatal in kidney transplant recipients with anti-rejection therapy. Mucorales species usually produce thrombotic phenomena, associated with necrosis and parenchymal destruction that caused a fatal uncontrolled haemoptysis in our patient. Early diagnosis is important in order to perform any surgical treatment and to administer amphotericin B.


Subject(s)
Hemoptysis/etiology , Kidney Transplantation , Lung Diseases, Fungal/microbiology , Mucormycosis/microbiology , Postoperative Complications/microbiology , Rhizomucor/isolation & purification , Amphotericin B/therapeutic use , Antifungal Agents/therapeutic use , Biopsy, Fine-Needle , Diabetes Mellitus, Type 2/complications , Diabetic Nephropathies/surgery , Fatal Outcome , Female , Humans , Immunocompromised Host , Immunosuppressive Agents/adverse effects , Immunosuppressive Agents/therapeutic use , Kidney Failure, Chronic/surgery , Lung/microbiology , Lung/pathology , Lung Diseases, Fungal/complications , Lung Diseases, Fungal/drug therapy , Middle Aged , Mucormycosis/complications , Mucormycosis/drug therapy , Postoperative Complications/drug therapy
5.
J Bronchology Interv Pulmonol ; 21(1): 51-3, 2014 Jan.
Article in English | MEDLINE | ID: mdl-24419187

ABSTRACT

We present the case of a 33-year-old woman who was being treated for bronchial asthma for 4 years. A tracheal tumor was evident on a computed tomography of the thorax and removed with argon plasma coagulation. It was diagnosed as pleomorphic adenoma of the trachea. It is a rare tracheal tumor without definite treatment guidelines. Our endoscopic approach to this rare lesion is discussed.


Subject(s)
Adenoma, Pleomorphic/surgery , Tracheal Neoplasms/surgery , Adenoma, Pleomorphic/pathology , Adult , Female , Humans , Tracheal Neoplasms/pathology
7.
Cir Cir ; 81(2): 93-7, 2013.
Article in Spanish | MEDLINE | ID: mdl-23522308

ABSTRACT

INTRODUCTION: When compared with conventional surgery, bronchoscopy-guided percutaneous tracheostomy has demonstrated some advantages. We compare the results obtained with bronchoscopy-guided percutaneous tracheostomy performed by Intensive Care Unit personnel with those of conventional surgery. METHODS: Prospective and descriptive cohort of patients admitted to a respiratory intensive care unit from March 2010 to March 2012. RESULTS: A total of 510 patients were admitted to the respiratory Intensive Care Unit. Tracheostomy was performed in 51 (10%); of which, 27 (53%) underwent bronchoscopy-guided percutaneous tracheostomy, and 24(47%) underwent tracheostomy by conventional surgery. There were no differences between bronchoscopy-guided percutaneous tracheostomy and conventional surgery groups in age (52 ± 16 vs 53 ± 18 years, p = 0.83). Simplified Acute Physiology Score-3 differed among groups (59.4 ± 11.2 vs 51.5 ± 14.3, p = 0.03). Indications for performing tracheostomy were prolonged intubation (74.1% vs 62.5%, p = 0.55), neurologic impairment (22.2% vs 16.6%, p = 0.88), and laryngeal disease (3.7% vs 20.8%, p 0.14). Mean time between intubation and tracheostomy was 13.3 days (range 4-45) vs 13.4 days (range 2-40). There were three minor complications in bronchoscopy-guided percutaneous tracheostomy patients, transient bigeminism in one, and moderate bleeding in two, and one minor complication of moderate bleeding in one patient in the conventional surgery group, p = 0.68. CONCLUSION: Bronchoscopy-guided percutaneous tracheostomy is a versatile and safe alternative for conventional tracheostomy when performed in Intensive Care Unit by personnel with expertise and appropriate training.


Subject(s)
Bronchoscopy/methods , Critical Care/methods , Respiratory Care Units , Tracheostomy/methods , Video-Assisted Surgery , Adult , Aged , Bronchoscopy/statistics & numerical data , Diagnosis-Related Groups , Female , Hospitals, General , Humans , Intubation, Intratracheal , Laryngeal Diseases , Male , Middle Aged , Nervous System Diseases , Personnel, Hospital , Postoperative Hemorrhage/etiology , Prospective Studies , Tracheostomy/adverse effects , Tracheostomy/statistics & numerical data
9.
Rev. Inst. Nac. Enfermedades Respir ; 19(3): 180-189, jul.-sep. 2006. ilus, graf, tab
Article in Spanish | LILACS | ID: lil-632596

ABSTRACT

Se determinó la frecuencia de los hallazgos observados en el Servicio de Broncoscopía del Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, en las broncoscopías realizadas del 1º de 180 enero al 31 de diciembre de 2005, captando la información en una hoja basada en las alteraciones descritas por Shigeto Ikeda. De las 923 broncoscopías realizadas, se incluyen las de 595 adultos en quienes se exploró todo el árbol bronquial. No se incluyeron los enfermos menores de 18 años o con exploración parcial. Fueron 334 del sexo masculino y 261 del femenino. Se utilizaron videofibrobroncoscopios de 4.9 y 6.3 mm de diámetro externo. En 67 broncoscopías, 11.2%, no se encontraron alteraciones. En 528 hubo una o más, sumando en total 1,208 alteraciones. Los cambios anormales orgánicos de la pared bronquial fueron los más frecuentes con 637, 52.7%; las anormalidades endobronquiales 320, 26.4%; las sustancias anormales en la luz bronquial 232, 19.2%; finalmente, alteraciones dinámicas en 19, 1.5%. Predominan los cambios relacionados con cáncer. Se incluyen imágenes representativas.


During 2005 we did a prospective study to determine the frequency of macroscopic findings during conventional white light bronchoscopy; findings were registered in a database specifically designed for this purpose according to Shigeto Ikeda's bronchoscopic findings classification. Five hundred and ninety five adults (334 males, 261 females) underwent a complete bronchoscopic examination; we did not include incomplete studies nor cases without photo or videorecordings; a 4.9 and a 6.3 mm external diameter fiberoptic videobronchoscopes were used. We did not find abnormalities in 11.2%; the rest, 88.8% had one to four abnormalities for a total of 1208 abnormalities; 637 organic changes of the bronchial wall (52.7%), 320 endobronchial abnormalities (26.4%), 232 abnormal substances in the lumen of the airways (19.2%) and 19 functional dynamic disorders (1.5%). Lung cancer associated abnormalities were the commonest bronchoscopic findings. Representative images are shown.

12.
Rev. Inst. Nac. Enfermedades Respir ; 18(2): 103-108, abr-jun. 2005. ilus, tab
Article in Spanish | LILACS | ID: lil-632541

ABSTRACT

Objetivo: Informar los resultados iniciales en la extracción de cuerpos extraños de la vía aérea de pacientes pediátricos mediante broncoscopía flexible. Material y métodos: Todos los pacientes menores de 18 años de edad referidos al Servicio de Broncoscopía del Instituto Nacional de Enfermedades Respiratorias con diagnóstico de aspiración de cuerpo extraño durante el periodo de marzo a diciembre de 2004. Resultados: Ocho pacientes entre 18 meses y 12 años (promedio 3 años, 5 meses), 5 del género masculino y 3 del femenino. En 4, el cuerpo extraño estaba en tráquea, 1 en bronquio intermediario, 1 en bronquio para el lóbulo inferior izquierdo y 2 en bronquio principal derecho. En 6 se logró extraer el cuerpo extraño en el primer intento con un broncoscopio flexible de 6.3 mm de diámetro, no se presentaron complicaciones mayores. En 2 pacientes, la extracción fue imposible con instrumental flexible y se realizó con broncoscopio rígido; en ambos, el cuerpo extraño estaba firmemente impactado en el bronquio después de tres meses y un año, respectivamente, de haber sido aspirado. No se presentaron complicaciones mayores. Conclusiones: Este estudio aporta evidencia útil para apoyar la broncoscopía flexible en la extracción de cuerpos extraños de las vías aéreas de pacientes pediátricos.


Objective: Report our experience in the removal of tracheobronchial foreign bodies in infants and children by flexible bronchoscopy. Patients and methods: All infants and children referred to the Department of Bronchoscopy from March to December 2004. Results: Eight patients from 18 months to 12 years, average 3 years and 5 months; 5 male, 3 female. Localization: 4 in the trachea, 1 in the intermediary bronchus, 1 in the left lower lobe bronchus and 2 in the main right bronchus. The foreign body was removed at the first attempt in 6 cases with a 6.3 mm dm flexible bronchoscope. Rigid bronchoscopy was successfully used in the other 2 after failure with the flexible instrument because the foreign bodies were heavily impacted; they had been aspirated 3 and 12 months before. There were no major complications. Conclusions: This study provides support for the removal of tracheobronchial foreign bodies in infants and children by flexible bronchoscopy.

13.
Gac. méd. Méx ; 131(5/6): 587-90, sept.-dic. 1995. ilus
Article in Spanish | LILACS | ID: lil-174093

ABSTRACT

En 1977 se informó de 34 muertes por neumonía en 221 asistentes a la Convención de la Legión Americana en Filadelfia. El agente causal fue identificado y llamado Legionella pneumophila. La legionellosis es una enfermedad de distribución mundial, pero en México sólo hay un caso informado, posiblemente por no considerarse en el diagnóstico diferencial de las neumonías adquiridas en la comunidad. Informamos el caso de una paciente previamente sana en la que se diagnosticó una neumonía secundaria a Legionella pneumophila


Subject(s)
Adult , Humans , Female , Clavulanic Acids/therapeutic use , Amikacin/therapeutic use , Amphotericin B/therapeutic use , Blood Chemical Analysis/methods , Ceftazidime/therapeutic use , Erythromycin/therapeutic use , Fluconazole/therapeutic use , Intensive Care Units/standards , Legionellosis/physiopathology , Legionnaires' Disease/diagnosis , Pneumonia/physiopathology , Penicillins/therapeutic use , Radiography , Ticarcillin/therapeutic use
14.
Rev. Inst. Nac. Enfermedades Respir ; 7(2): 137-40, abr.-jun. 1994. tab, ilus
Article in Spanish | LILACS | ID: lil-143276

ABSTRACT

Se conoce perfectamente la distribución segmentaria del lóbulo medio y la língula, sin embargo, existen algunas variantes que deben de tomarse en cuenta para una correcta exploración endoscópica. Se proponen puntos de referencia para la mejor identificación de la orientación, con respecto a los planos medial, sagital y coronal, del lóbulo medio y la língula. Todo endoscopista del aparato respiratorio debe de conocer la anatomía bronquial, además, de identificar las variantes anatómicas del árbol bronquial. Estas variantes anatómicas explican el por qué de situaciones atípicas o aberrantes de los diferentes procesos parenquimatosos


Subject(s)
Middle Aged , Humans , Male , Female , Bronchi/anatomy & histology , Bronchoscopy/statistics & numerical data
15.
Rev. Inst. Nac. Enfermedades Respir ; 5(1): 19-27, ene.-mar. 1992. ilus, tab
Article in Spanish | LILACS | ID: lil-118104

ABSTRACT

Se presenta una breve revisión comparativas de las nomenclaturas bronquiales más conocidas. Se comentan los hallazgos anatómicos de 207 fibróncoscopías consignado las variaciones observadas en la distribución segmentaria y subsegmentaria del árbol bronquial. Se confirma la gran variabilidad de las ramificaciones bronquiales y se ilustran algunas variantes. Se concluye que el conocimiento preciso de la anatomía endoscópica es indispensable para practicar correctamente una broncoscopia.


Subject(s)
Humans , Bronchi/anatomy & histology , Bronchoscopy , Endoscopy
SELECTION OF CITATIONS
SEARCH DETAIL